HPV-independent squamous cell carcinoma (SCC) of the cervix is a rare subtype associated with aggressive clinical behavior and poor prognosis, as reported in limited studies with small sample sizes. This study aims to investigate the clinicopathological, immunohistochemical, and molecular characteristics of six cases of HPV-independent SCC. Formalin-fixed, paraffin-embedded tissues from six patients were analyzed using immunohistochemistry and Next-Generation Sequencing (NGS). Human papillomavirus (HPV) testing was performed using the Aptima HPV assay, and immunohistochemical markers, including p16, p53, PD-L1, HER2 and CK5/6 were evaluated. The median age at diagnosis was 62 years. Key histopathological features included an infiltrative-destructive growth pattern, pronounced keratinization, and extensive necrosis in the majority of cases. All tumors were p16-negative and high-risk HPV-negative by the Aptima HPV assay, confirming their HPV-independent status. One case exhibited p53 overexpression and HER2 positivity (score 3 +). Five out of six patients succumbed to the disease. FIGO stages ranged from IIB to IVB. Molecular analysis identified mutations in TP53 and PIK3CA, as well as novel CTNNB1 and TERT promoter mutations, and HER2 amplification . In five of six patients PD-L1 expression with at least CPS score of 2,5 was observed. HPV-independent cervical SCC typically affects older patients and is associated with poor clinical outcomes. This study highlights TP53 and PIK3CA mutations and novel findings, including CTNNB1, TERT promoter mutations, and HER2 amplification. The observed PD-L1 expression patterns may suggest potential benefits from immunotherapy. Further research is warranted to better understand the clinicopathologic characteristics and molecular drivers of HPV-independent SCC and to explore novel therapeutic strategies.
Abdominal actinomycosis, a rare and often misdiagnosed condition caused by Actinomyces israelii, typically a commensal organism in the oral cavity and gastrointestinal tract, can become pathogenic, leading to chronic granulomatous infections that mimic various abdominal pathologies, including malignancies. We present a case of a 59-year-old male with coronary artery disease and type 2 diabetes who presented with severe abdominal pain, initially diagnosed as acute appendicitis. During exploratory laparotomy, an ileocecal band mimicking a congenital anomaly was discovered. Histopathological examination confirmed abdominal actinomycosis, revealing clusters of Actinomyces bacteria surrounded by acute inflammatory cells. The patient was successfully treated with surgical intervention and prolonged penicillin therapy, with no recurrence during a four-month follow-up. This case highlights the diagnostic challenges posed by abdominal actinomycosis and emphasizes the importance of considering it in the differential diagnosis of abdominal masses and appendicitis-like symptoms.
Intravascular lobular capillary hemangioma (ILCH), also known as intravenous pyogenic granuloma, is a benign vascular lesion with a distinctive lobular arrangement of capillaries. It is typically confined to the head, neck, and upper extremities, and its occurrence in the testicular region is exceedingly rare. Here, we present a case of a 68-year-old male who was initially diagnosed with a testicular tumor based on imaging studies but was later found to have an ILCH located in the epididymis. This case underscores the diagnostic challenges posed by this rare entity due to its unusual presentation and mimicking of malignant conditions.
Gastric adenocarcinoma carries high mortality despite modern multimodal therapy. Reliable biomarkers that refine prognosis and suggest therapeutic strategies are needed. We evaluated the clinicopathologic and prognostic significance of folate receptor-alpha (FOLR1) expression in a large single-institution cohort. We retrospectively analyzed 259 gastrectomy specimens (2016–2025). Immunohistochemistry included FOLR1 (H-score 0–300), HER2, PD-L1 (CPS; positive if ≥ 1), p53 status, and MMR proteins (MLH1/MSH2/MSH6/PMS2). The FOLR1 cut-off for recurrence-free survival (RFS) was derived by Receiver operating characteristic(ROC) analysis. Associations were tested with Chi-square or Fisher’s exact tests and Spearman correlation; survival was assessed by Kaplan–Meier and Cox regression. ROC for RFS yielded an area under the curve (AUC) of 0.653 (95% CI 0.578–0.728; p < 0.001) and defined a FOLR1 H-score cut-off of 40; ROC for overall survival (OS) was not significant (AUC 0.528; p = 0.443). Using this threshold, FOLR1-high tumors (≥ 40; n = 48) showed significantly shorter RFS (mean 24.1 vs 266.6 months; log-rank p < 0.001) and shorter OS (mean 32.4 vs 53.9 months; p = 0.047) than FOLR1-low tumors. On univariate analysis, FOLR1-high predicted inferior RFS (HR 4.15; 95% CI 2.67–6.47; p < 0.001); in multivariate Cox modeling it remained an independent predictor (HR 1.99; 95% CI 1.15–3.45; p = 0.015). FOLR1-high status associated with advanced T stage ( p = 0.045), vascular invasion ( p < 0.001), higher M1 frequency ( p < 0.001), and proximal location ( p = 0.038). It correlated with PD-L1 positivity ( p < 0.001; FOLR1 H-score vs PD-L1 CPS Spearman r = 0.286; p < 0.001), HER2 positivity ( p < 0.001), and p53 mutant pattern ( p < 0.001), and was inversely associated with MMR deficiency ( p = 0.010). N-stage distribution was not different overall, although a linear trend toward higher nodal stage with FOLR1-high was observed ( p = 0.013). No significant associations were found with Lauren or WHO subtype, histologic grade, lymphatic or perineural invasion, extracapsular extension, neoadjuvant therapy, age, or sex. High FOLR1 expression identifies a biologically aggressive subset of gastric adenocarcinoma with inferior RFS and independent prognostic value. Its concurrent association with PD-L1 and HER2, together with relative absence in dMMR tumors, supports biomarker-guided strategies that consider FOLR1 alongside HER2 and PD-L1, and provides a rationale to explore FOLR1-targeted therapies in selected patients.